What's new

Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised

Apr 4, 2025 - 11:41
 0
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

JING™ awarded EcoVadis Gold for sustainable practices

Next Article

UK egg business sold to Italian Eurovo Group

Related Posts

Product Management Service (PMS) questions and aswers clinic - June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2025, 11:00 (CEST) to 17 June 2025, 12:00 (CEST)

Product Management Service (PMS) questions and aswers c...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pregabalin, Date of authorisation: 10/04/2014, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Template for response to list of questions/list of outs...

Mar 28, 2025  0